Provided by Tiger Trade Technology Pte. Ltd.

SHINEWAY PHARM

7.210
-0.135-1.84%
Volume:625.19K
Turnover:4.52M
Market Cap:5.96B
PE:5.72
High:7.345
Open:7.300
Low:7.120
Close:7.345
52wk High:7.784
52wk Low:5.643
Shares:827.00M
HK Float Shares:827.00M
Volume Ratio:12.60
T/O Rate:0.08%
Dividend:1.42
Dividend Rate:19.70%
EPS(LYR):1.260
ROE:10.05%
ROA:3.90%
PB:0.62
PE(LYR):5.72
PS:1.92

Loading ...

China Shineway FY26 H1 Profit Drops 23.7% to RMB 469.16 Million; Revenue Falls 28.5% to RMB 1.18 Billion

Reuters
·
Aug 27

China Shineway Pharma Declares RMB 0.8 Fy2026 Second Interim Dividend

Reuters
·
Aug 27

China Shineway Pharma Schedules Board Meeting on Interim Results, Dividend Decision

Reuters
·
Aug 17

Does China Shineway Pharmaceutical Group (HKG:2877) Deserve A Spot On Your Watchlist?

Simply Wall St.
·
Jul 17

Shineway Pharma AGM Clears All Motions; Confirms Board Line-up and 20% Share Issuance Mandate

Bulletin Express
·
May 28

SHINEWAY PHARM Reports 18% Revenue Decline in Q1 2026

Stock News
·
May 07

China Shineway Pharmaceutical - Q1 Turnover RMB624 Mln

THOMSON REUTERS
·
May 07

China Shineway Q1 turnover falls 18% to RMB 624 million

Reuters
·
May 07

Tianjin Binhai Teda Logistics unit Yuan Da Logistics pays RMB 7.16 million in back taxes

Reuters
·
Apr 30

China Shineway Pharmaceutical Releases 2025 Annual and ESG Reports; AGM Materials Now Online

Bulletin Express
·
Apr 23

China Shineway Pharmaceutical publishes 2025 Annual Report, AGM documents and ESG Report

Bulletin Express
·
Apr 23

Shineway Pharmaceutical’s 2025 ESG Report: Higher Carbon Footprint Offset by Waste-Reduction Gains and Strong Social Commitments

Bulletin Express
·
Apr 23

Shineway Pharmaceutical to Seek Shareholders’ Approval on Financials, Board Re-elections and 20% Issuance Mandate at 28 May 2026 AGM

Bulletin Express
·
Apr 23

China Shineway Pharmaceutical publishes 2025 annual report

Reuters
·
Apr 23

SHINEWAY PHARM 2025年业绩:收入承压净利逆势增长,聚焦创新中药与成本管控

Bulletin Express
·
Apr 23

Shineway Pharma Shares Climb Over 4% as Peach Red Four Substance Decoction Granules Receive Market Approval

Stock News
·
Apr 20